STARCO
June 23, 2026
Theater 1
Type: Company Presentation
Focus Area:
Diagnostics and Personalized Medicine
STARCO is building an AI-driven platform that transforms traditional histopathology by integrating spatial statistics, deep learning, and genetic profiling spatial transcriptomics to enhance cancer diagnostics and prognosis. STARCO’s tools predict cancer progression and metastasis and improve cancer diagnostics amid pathologist shortages. These clinically interpretable tools provide explainable visual and quantitative outputs to reduce diagnostic delays, improve treatment precision, and enable early cancer trajectory insights.
Company HQ City:
Brisbane
Company HQ State:
Queensland
Company HQ Country:
Australia
Year Founded:
2025
Lead Product in Development:
TBD
CEO
Quan Nguyen (CSO), Dale Pavlovski (CEO)
Development Phase of Lead Product
Pre-Clinical
When you expect your next catalyst update?
December 2026
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}